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Background: Evidence has demonstrated that central fat distribution produces the most profound metabolic
abnormalities and is associated with an increased risk of atherosclerotic cardiovascular diseases. We aimed to
investigate whether the indexes of central fat distribution, including waist-to-height ratio (WHtR) and visceral fat
area (VFA), were stronger risk factors of subclinical atherosclerosis than body mass index (BMI) in Chinese adults.
Methods: A total of 3381 participants aged 40 years or older without history of cardiovascular diseases (CVD) were
enrolled in the present cross-sectional study from the Songnan community, Shanghai, China. Height, weight and
waist circumference (WC) were measured by experienced physicians. High-resolution B-mode ultrasonography was
performed to measure carotid intima-media thickness (CIMT). Regional adiposity was measured by a dual-source
computed tomography (CT) scanner.
Results: Normal weight but central obesity group (BMI < 23 kg/m2 and WHtR > 0.5) had higher levels of systolic
blood pressure (SBP), fasting plasma glucose (FPG), 2 h post-load glucose (2 h PG), Hemoglobin A1c (HbA1c), and
CIMT, as well as an elevated prevalence of hypertension and diabetes compared with overweight/obesity but not
central obesity group (BMI ≥ 23 kg/m2 and WHtR ≤ 0.5). In logistic regression analysis, WHtR > 0.5 was significantly
and independently associated with elevated CIMT (odds ratio [OR] 1.30, 95% confidence interval [CI] 1.01-1.68,
p value = 0.044). Similar association was noted for each standard deviation (SD) increase of WHtR (OR 1.25, 95%
CI 1.07-1.47, p value = 0.006). Stepwise multiple linear regression analysis revealed that both WHtR and VFA were
important determinants of CIMT, independent of other well-recognized risk factors (both p values < 0.01).
Conclusions: WHtR and VFA were associated with CIMT, independent of BMI and conventional CVD risk factors.
Given the relatively high cost and complexness of VFA measurement, WHtR could be a more convenient and
appropriate measure of abdominal obesity in clinical practice.
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As known to all, overweight and obesity are inter-
national problems and associated with metabolic disor-
ders and cardiovascular diseases (CVD) [1,2]. In recent
years, evidence has demonstrated that abdominal accu-
mulation of fat tissue produces the most profound meta-
bolic abnormalities and is associated with an increased
risk of atherosclerotic CVD [3]. Accumulation of visceral
fat is a major component of central obesity which is
more important for the development of metabolic disor-
ders including insulin resistance [4-6], type 2 diabetes
[4,7,8], and metabolic syndrome [9]. Anthropometric
measurement is useful in clinical practice due to its con-
venience and non-invasiveness [10]. The waist-to-height
ratio (WHtR) is an important anthropometric index of
central obesity that circumvents the limitations of waist
circumference (WC) [11]. Because of the inclusion of
height into the index, any potential confounding of car-
diometabolic risk by height is avoided. A prospective study
[12] showed that several different measures of abdominal
obesity [WHtR > WC > waist-to-hip ratio (WHR)] were
strong predictors of stroke among more than 45,000
women below age 60. WHtR is also a better predictor than
WC for diabetes, dyslipidaemia, hypertension and CVD
risk in both sexes in populations of various nationalities
and ethnic groups [12]. In addition, there are also more
complex measurements on central adiposity that could
improve CVD prediction above and beyond what have
already been achieved by simple anthropometric measures
[13]. Among them, visceral fat area (VFA) is an accurate
and important indicator of central fat distribution.
Carotid intima-media thickness (CIMT) is accepted as
an indicator of subclinical atherosclerosis [14] and a risk
factor for myocardial infarction and stroke in elderly
adults [15]. However, few studies have investigated the
association of VFA with CIMT in Chinese population.
Furthermore, little evidence is available on the associ-
ation between WHtR and subclinical atherosclerosis in
various body mass index (BMI) categories. In the current
study, we aimed to investigate the association between
CIMT and indexes of central fat distribution (WHtR and
VFA) in a middle-aged and elderly Chinese population.
Methods
Study sample
A total of 4012 subjects were recruited from the Songnan
community, Baoshan, Shanghai in 2009. All the resi-
dents aged 40 years old or above were invited to receive
measurements of weight, height and WC. WHtR was
calculated as WC divided by height in the same unit.
BMI was calculated as weight in kilograms divided by
height in meters squared. Based on the calculation of
WHtR and BMI, participants were categorized into four
groups: 1) normal group: BMI < 23 kg/m2 and WHtR ≤ 0.5;2) overweight/obesity but not central obesity group
(OW/OB-NC): BMI ≥ 23 kg/m2 and WHtR ≤ 0.5; 3) nor-
mal weight but central obesity group (NW-C): BMI <
23 kg/m2 and WHtR > 0.5; and 4) overweight/obesity
and central obesity group (OW/OB-C): BMI ≥ 23 kg/m2
and WHtR > 0.5. We excluded those people who had a
history of previous cardiovascular diseases (myocardial
infarction, unstable angina, percutaneous coronary inter-
vention, or stroke), or impaired liver or renal function
(aminotransferase more than twice the upper limit of
the normal range, serum creatinine level greater than
133 μmol/l [1.5 mg/dl] or estimated glomerular filtra-
tion rate less than 60 ml/min/1.73 m2), who were preg-
nant or having significant medical comorbidities, or
had missing data on CIMT and WHtR. Finally, 3381
participants were included in analysis. In addition, a
subgroup of participants underwent coronary computed
tomography (CT) angiography to detect coronary ath-
erosclerosis and abdominal CT scanning to measure
subcutaneous and visceral fat. The subgroup included
all participants with diabetes or prediabetes, and 50% of
participants with normal glucose regulation using simple
random sampling, from the original 4012 participants
after excluding those with following characteristics: 1) age
over 60, 2) having symptoms of coronary artery disease,
3) having a history of previous CVD, 4) having abnormal
Q waves on resting electrocardiogram (ECG), 5) with a
prior diagnosis of diabetes more than 5 years, 6) having im-
paired liver or renal function, 7) being pregnant or having
significant medical comorbidities, 8) having X-ray examin-
ation or CT scan within one year, 9) with tachycardia or
arrhythmia such as atrial fibrillation on ECG, and 10) hav-
ing a history of allergic reaction to iodine-containing con-
trast agent. A total of 942 participants were recruited
and 593 responded, among which 569 had abdominal
CT scanning. After excluding participants with missing
data on CIMT, blood pressure (BP), and 2 h post-load
glucose (2 h PG), 542 participants were eventually in-
cluded for the subgroup analysis.
This study was approved by the Institutional Review
Board of Rui-Jin Hospital, Shanghai Jiao-Tong University
School of Medicine and was in accordance with the
principle of the Helsinki Declaration II. The written in-
formed consent was obtained from each participant.
Measurement of CIMT
CIMT on the far wall of the right and left common carotid
arteries, 1.5 cm proximal to the bifurcation, was measured
by a trained sonographer using a high-resolution B-mode
tomographic ultrasound system (Esaote Biomedica SpA,
Genova, Italy) with a linear 7.5-MHz transducer. The
transducer was manipulated so that the lumen diameter
was maximized in the longitudinal plane. CIMT was mea-
sured online during end diastole as the distance from the
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echogenic line. The first and second lines represent the
lumen-intimal interface and the collagen-contained upper
layer of tunic adventitia, respectively. The greater value of
the right and left common CIMT was used for analysis.
Measurement of VFA
Regional adiposity was measured by a dual-source CT
scanner (SOMATOM Definition, Siemens Medical Solu-
tions, Forchheim, Germany). Visceral and subcutaneous
adiposity were measured at the midpoint between the
fourth and fifth lumbar vertebrae with participants in
the supine position. Fat area was calculated by FatScan
version 2.0 software (N2 System Co., Osaka, Japan) by
two independent observers. The intraperitoneal area was
defined manually by tracing its contour (the green line)
and the outline of abdominal wall was also circled (the
yellow line) on CT images using the software, which cal-
culated VFA and subcutaneous fat area (SFA) automatic-
ally (Figure 1). If readings between two observers differed
by more than 10%, a third observer who did not know the
results reanalyzed the images.
Assessment of covariates
The detailed information about medical history and life-
style including smoking and drinking status was obtained
using a standard questionnaire by trained physicians.
Current smoking status was defined as yes if the subject
smoked at least one cigarette per day or seven cigarettes
per week in the past 6 months. Current drinking status
was defined as yes if the subject consumed alcohol at least
once a week in the past 6 months. Body height, weight,
and WC were measured by experienced physicians.
Height and weight were recorded to the nearest 0.1 cm
and 0.1 kg while participants were wearing light indoor
clothing without shoes. WC was measured to the nearest
0.1 cm with participants in the standing position. BP was
measured at the non-dominant arm in a seated positionFigure 1 Distribution of abdominal fat as measured by FatScan
software on a CT image. The visceral fat was indicated in red, and
the subcutaneous fat was indicated in pink.after a 5-min rest using an automated electronic device
(OMRON Model HEM-752 FUZZY’ Omron Co., Dalian,
China). Three measurements were taken in one minute
apart and the average of the three measurements was used
in analysis.
All participants received a two-point (at 0 and 2 hrs) 75-g
oral glucose tolerance test after an overnight fast of more
than 10 hrs. The measurements of fasting plasma glucose
(FPG), 2 h PG, triglycerides (TG), total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C), and high-
density lipoprotein cholesterol (HDL-C) were performed
on an autoanalyzer (ADVIA-1650 Chemistry Analyzer;
Bayer Diagnostics, Tarrytown, NY, USA). Hemoglobin A1c
(HbA1c) was measured by high performance liquid chro-
matography (HPLC; Bio-Rad, Hercules, CA, USA). The
index of homeostasis model assessment of insulin resist-
ance (HOMA-IR) was calculated according to the formula:
HOMA-IR = fasting insulin concentrations (mIU/L) × FPG
concentrations (mmol/L)/22.5.
Definitions
Central obesity was defined as WHtR > 0.5 for males and
females [16].
Overweight/obesity was defined as BMI ≥ 23 kg/m2 in
Asians [17,18].
Statistical analysis
SAS version 9.1 (SAS Institute, Cary, NC) was used for
database management and statistical analysis. Data are pre-
sented as means ± SD or medians (interquartile ranges) for
continuous variables or numbers (percentages) for categor-
ical variables. Measurements with a skewed distribution,
such as TG, HbA1c, HOMA-IR, and CIMT were normal-
ized by logarithmic transformation. Comparisons of means
and proportions were performed with variance analysis and
x2 tests, respectively. Pearson correlation coefficients were
used to measure linear associations between different risk
factors and CIMT. Stepwise multiple linear regression ana-
lysis was used to identify independent determinants of
CIMT. In addition, we used the logistic regression analysis
to evaluate the association of WHtR with elevated CIMT
by categorized WHtR (WHtR ≤ 0.5 and WHtR > 0.5) using
WHtR ≤ 0.5 as the reference as well as per standard
deviation (SD) increment of WHtR. In the present study,
subjects with CIMT values above the upper quartile
(≥ 0.7 mm) of the entire study population were defined as
those with elevated CIMT. Adjusted odds ratio (OR) and
corresponding 95% confidence interval (CI) were calculated
and a p value < 0.05 was considered statistically significant.
Results
Clinical characteristics of the study population
Compared with the normal group, not only OW/OB-C
but also NW-C group had higher systolic BP (SBP),
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TC, TG, LDL-C and CIMT, and lower HDL-C, as well
as an elevated prevalence of hypertension and diabetes.
Compared with OW/OB-NC group, NW-C and OW/
OB-C groups had higher SBP, FPG, 2 h PG, HbA1c,
CIMT, and the prevalence of hypertension and diabetes.
There was no significant difference of lipid profiles be-
tween OW/OB-NC and NW-C groups (p value > 0.05).
However, TC, TG, and LDL-C gradually increased and
HDL-C gradually decreased among four groups (p for
trend < 0.0001, Table 1).
Compared with NW-C group, OW/OB-C group also
had higher SBP, DBP, HOMA-IR, TG, LDL-C, CIMT and
lower HDL-C, as well as a higher prevalence of hyperten-
sion and diabetes.
WHtR and CIMT
Simple regression analyses revealed that age, sex, SBP,
DBP, FPG, 2 h PG, HbA1c, HOMA-IR, TC, TG, LDL-C,
HDL-C, WHtR and BMI were significantly correlatedTable 1 Clinical characteristics of the study population accord
WHtR ≤ 0.5 (N = 785)
BMI < 23 kg/m2 (N = 592) BMI ≥ 23 kg/m2 (N = 19
Age (years) 57.0 ± 8.7 54.6 ± 7.2†
Male, n (%) 249 (42.1) 87 (45.1)
Current smokers, n (%) 143 (24.2) 52 (27.0)
Alcohol drinking, n (%) 102 (17.2) 35 (18.1)
Hypertension, n (%) 179 (30.2) 69 (35.8)
SBP (mmHg) 126.5 ± 19.1 128.9 ± 17.4
DBP (mmHg) 74.2 ± 9.6 77.8 ± 9.6†
HbA1c (%)* 6.0 (5.7-6.3) 5.9 (5.6-6.2)
FPG (mmol/L) 5.46 ± 1.88 5.30 ± 1.49†
2 h PG (mmol/L) 8.4 ± 5.3 7.6 ± 3.8
HOMA-IR* 0.91(0.61-1.41) 1.26 (0.85-1.80)†
Diabetes, n (%) 122 (20.6) 27 (14.0)†
TC (mmol/L) 4.98 ± 0.90 5.04 ± 0.88
TG (mmol/L)* 1.01 (0.77-1.37) 1.19 (0.84-1.84)†
LDL-C (mmol/L) 2.19 ± 0.61 2.29 ± 0.62
HDL-C(mmol/L) 1.51 ± 0.35 1.38 ± 0.34†
Anthropometric index
WHtR 0.46 ± 0.03 0.48 ± 0.01†
BMI (kg/m2) 20.6 ± 1.6 24.2 ± 1.1†
CIMT (mm)* 0.6 (0.5-0.6) 0.6 (0.5-0.6)
SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma gluc
of insulin resistance; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprote
ratio; BMI, body mass index; CIMT, carotid intima-media thickness.
*Medians with interquartile ranges.
†p < 0.05 versus the WHtR ≤ 0.5 and BMI < 23 kg/m2 group.
‡p < 0.05 versus the WHtR ≤ 0.5 and BMI ≥ 23 kg/m2 group.
#p < 0.05 versus the WHtR > 0.5 and BMI < 23 kg/m2 group.with CIMT (p value < 0.01). After performing multiple
stepwise linear regression analysis, we found that age,
sex, SBP, DBP, HbA1c, LDL-C and WHtR were inde-
pendent determinants of CIMT (p value < 0.0001). How-
ever, BMI did not enter the final step in stepwise
multiple linear regression analysis (Table 2).
In logistic regression analysis (Table 3), the risk of ele-
vated CIMT was increased in WHtR > 0.5 group (OR 1.90,
95% CI 1.55-2.35) after adjusted for age, sex, smoking and
drinking status (Model 1). WHtR > 0.5 was still signifi-
cantly associated with elevated CIMT (OR 1.45, 95% CI
1.14-1.83) after further adjustment for SBP, DBP, 2 h PG,
HbA1c, HOMA-IR, TG, LDL-C, HDL-C and medical
treatment for diabetes and hypertension based on model 1
(Model 2). After adjustment for BMI based on model 2
(Model 3), WHtR > 0.5 remained to be an independent
risk factor of elevated CIMT (OR 1.30, 95% CI 1.01- 1.68).
In three models, each1-SD increase in WHtR conveyed
1.40-fold, 1.24-fold, or and 1.25-fold higher risks of ele-
vated CIMT, respectively (all p values < 0.05; Table 3).ing to WHtR and BMI categories
WHtR > 0.5 (N = 2596)
3) BMI < 23 kg/m2 (N = 308) BMI ≥ 23 kg/m2 (N = 2288) p for trend
62.6 ± 10.8†‡ 60.5 ± 9.5†‡# < 0.0001
97 (31.5) † 929 (40.6) ‡# 0.4886
64 (20.8) 468 (20.5) 0.0182
49 (15.9) 433 (19.0) 0.2999
160 (52.0) †‡ 1428 (62.4)†‡# < 0.0001
138.1 ± 23.3†‡ 141.1 ± 21.3†‡# < 0.0001
77.3 ± 10.2† 80.0 ± 10.0†‡# < 0.0001
6.0 (5.7-6.6)†‡ 6.2 (5.8-6.9)†‡ < 0.0001
5.80 ± 2.18†‡ 5.91 ± 1.94†‡ < 0.0001
9.8 ± 6.0†‡ 10.4 ± 5.4†‡ < 0.0001
1.31 (0.83-2.00)† 2.07 (1.38-3.22)†‡# < 0.0001
83 (27.0)†‡ 796 (34.8)†‡# < 0.0001
5.16 ± 0.98† 5.21 ± 1.00†‡ < 0.0001
1.30 (0.97-1.99)† 1.59 (1.14-2.29) †‡# < 0.0001
2.34 ± 0.66† 2.45 ± 0.71†‡# < 0.0001
1.41 ± 0.33† 1.31 ± 0.28†‡# < 0.0001
0.53 ± 0.03†‡ 0.57 ± 0.05†‡# < 0.0001
21.8 ± 1.2†‡ 26.9 ± 3.0†‡# —
0.6 (0.6-0.7) †‡ 0.6 (0.6-0.7)†‡ < 0.0001
ose; 2 h PG, 2 h post-load glucose; HOMA-IR, homeostasis model assessment
in cholesterol; HDL-C, high-density lipoprotein cholesterol; WHtR, waist-height
Table 2 Univariate and multiple stepwise linear regression analysis of risk factors associated with CIMT
Univariate Stepwise
r p value β ± SE p value
Age (years) 0.3848 < 0.0001 0.0039 ± 0.0003 < 0.0001
Sex (male = 1, female = 2) −0.2379 < 0.0001 −0.0594 ± 0.0062 < 0.0001
SBP (mmHg) 0.3079 < 0.0001 0.0015 ± 0.0002 < 0.0001
DBP (mmHg) 0.0732 < 0.0001 −0.0014 ± 0.0003 < 0.0001
HbA1c (%) 0.2083 < 0.0001 0.1774 ± 0.0317 < 0.0001
FPG (mmol/L) 0.1472 < 0.0001 — —
2 h PG (mmol/L) 0.1977 < 0.0001 — —
HOMA-IR 0.1216 < 0.0001 — —
TC (mmol/L) 0.0394 0.0220 — —
TG (mmol/L) 0.0485 0.0047 — —
LDL-C (mmol/L) 0.1148 < 0.0001 0.0220 ± 0.0035 < 0.0001
HDL-C (mmol/L) −0.0974 < 0.0001 — —
WHtR 0.1974 < 0.0001 0.1810 ± 0.0418 < 0.0001
BMI (kg/m2) 0.1051 < 0.0001 — —
r, correlation coefficient; β, regression coefficient; SE, standard error.
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Pearson correlation analyses revealed that age, sex, SBP,
DBP, FPG, 2 h PG, HbA1c, HOMA-IR, TG, HDL-C,
VFA, WHtR, and BMI were significantly associated with
CIMT (p value < 0.01). Stepwise multiple linear regres-
sion analyses revealed that apart from well-recognized
risk factors of CIMT such as age, sex, SBP, and HbA1c,
VFA was also an independent determinant of CIMT
(Table 4).
Discussion
The present study provided important evidence that cen-
tral fat accumulation, as indicated by increased WHtR and
VFA, was associated with carotid atherosclerosis inde-
pendent of general fat distribution and other risk factors
in middle-aged and elderly Chinese without history of
CVD.
Prospective data from the Shanghai Women’s Health
Study revealed that high levels of BMI, WHR, WC, and
WHtR were all associated with significantly increased
risk of total, ischemic, and hemorrhagic stroke [19]. Ob-
servations from seventy-eight prospective and cross-Table 3 Levels of WHtR in relation to the risk of elevated CIM
WHtR Model 1 p value Mo
≤ 0.5 1.0 — 1.0
> 0.5 1.90 (1.55-2.35) < 0.0001 1.45
Each1-SD elevation 1.40 (1.29-1.53) < 0.0001 1.24
SD, standard deviation.
Model 1: adjusted for age, sex, smoking status and alcohol drinking status.
Model 2: further adjusted for SBP, DPB, HbA1c, 2 h PG, HOMA-IR, TG, LDL-C, HDL-C
Model 3: further adjusted for BMI based on model 2.sectional studies suggested that although WHtR, WC,
and BMI were all predictors of CVD, diabetes and re-
lated disorders, WHtR and WC were probably more reli-
able predictors than BMI [20]. Gelber RP et al. [21]
demonstrated that WHtR was statistically the best model
fit and had strongest associations with CVD, compared
with WC, WHR and BMI. Early detection and interven-
tion of risk factors of CVD are the key points for pre-
vention and delay of CVD development. CIMT is an
early indicator of CVD being widely adopted [22,23] and
BMI is recognized as an index of general fat distribution.
A number of previous studies [24-27] have demon-
strated the relationship between obesity and carotid ath-
erosclerosis. However, studies evaluating the associations
between WHtR or VFA and CIMT are limited.
In our study, subjects with central obesity alone (NW-C)
exhibited higher prevalences of cardiometabolic risk factors
and increased CIMT than subjects with general over-
weight/obesity (OW/OB-NC). Jose I Recio-Rodrigue
et al. [28] reported that measures of central obesity
(WHtR and WC) correlated better than BMI and body
fat percentage with subclinical atherosclerosis evaluatedT
del 2 p value Model 3 p value
— 1.0 —
(1.14-1.83) 0.0022 1.30 (1.01-1.68) 0.0444
(1.12-1.37) < 0.0001 1.25 (1.07-1.47) 0.0064
and medical treatment for diabetes and hypertension based on model 1.
Table 4 Univariate and multiple stepwise linear regression analysis of risk factors associated with CIMT in the
subgroup
Univariate Stepwise
r p value β ± SE p value
Age (years) 0.1481 0.0005 0.0027 ± 0.0012 0.0273
Sex (male = 1, female = 2) −0.2697 < 0.0001 −0.0373 ± 0.0145 0.0103
SBP (mmHg) 0.2383 < 0.0001 0.0011 ± 0.0003 < 0.0001
DBP (mmHg) 0.2397 < 0.0001 — —
HbA1c (%) 0.2008 < 0.0001 0.4848 ± 0.1359 0.0004
FPG (mmol/L) 0.1158 0.0070 — —
2 h PG (mmol/L) 0.1397 0.0011 — —
HOMA-IR 0.1153 0.0072 — —
TC (mmol/L) 0.0097 0.8218 — —
TG (mmol/L) 0.1261 0.0033 — —
LDL-C (mmol/L) 0.0525 0.2226 — —
HDL-C (mmol/L) −0.1173 0.0063 — —
VFA (cm2) 0.2854 < 0.0001 0.0004 ± 0.0001 0.0014
SFA (cm2) −0.0434 0.3122 — —
BMI (kg/m2) 0.1879 < 0.0001 — —
VFA, visceral fat area; SFA, subcutaneous fat area.
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hypertension. Our study also showed that WHtR was
significantly associated with CIMT after adjustment for
BMI and a set of cardiometabolic risk factors. A sys-
tematic review and meta-analysis confirmed that WHtR
was proved to be a superior tool for discriminating
obesity-related cardiometabolic risks compared with
BMI [12], and that WHtR might be a more useful clinical
screening tool than WC, with a weighted mean boundary
value of 0.5 [20]. In addition, VFA was an independent risk
factor for subclinical atherosclerosis rather than BMI and
SFA after adjustment for cardiometabolic risk factors in
our study. These results illustrated that central fat accumu-
lation was more important than general fat accumulation
in terms of affecting cardiometabolic and atherosclerotic
risks. Lee MJ et al. [29] reported that visceral fat thickness,
but not subcutaneous fat thickness, was independently as-
sociated with carotid atherosclerosis determined by CIMT
in peritoneal dialysis patients. Our study found a similar
association of visceral fat accumulation calculated as VFA
with CIMT in a general Chinese population. Although
VFA is more accurate than WHtR, the measurement of
VFA is costly and complicated. WHtR is obviously more
convenient in clinical practice.
Why does central fat accumulation correlate with ath-
erosclerosis? Some investigators reported that obesity-
associated systemic inflammation and oxidative stress
played a key role in the initiation, propagation, and de-
velopment of atherosclerosis [30]. Adipokines such as
leptin and plasminogen activator inhibitor type 1 aremostly produced by visceral adipose tissue. These adi-
pokines play important regulatory roles in a variety of
biological processes, including insulin resistance and
atherosclerosis [31-36]. Indulekha K et al. [37] reported
that visceral fat accumulated with increasing glucose
intolerance and was associated with decreased levels of
adiponectin and increased levels of high sensitive C-
reactive protein, tumor necrosis factor-alpha, oxidized
LDL, HOMA-IR and CIMT. Nakanishi-Minami T et al.
[38] reported that the duration of diabetes was an im-
portant factor in the development of coronary artery
disease and visceral fat reduction might be an import-
ant approach to improving insulin resistance for pa-
tients with visceral fat accumulation. Another study
showed that HOMA-IR and visceral adiposity, but not
BMI, can be used to categorize morbidly obese subjects
with or without metabolic and vascular impairment
who are thus potentially at risk of future cardiovascular
events [39]. Plasma thiobarbituric acid reactive sub-
stances, a biomarker of oxidative stress, was most
strongly associated with visceral adipose tissue (VAT),
which further implicates VAT as a pro-atherogenic re-
gion of adiposity. VAT is involved in the generation of
systemic oxidative stress and such redox perturbations
may play a causal role in the early subclinical stages of
CVD [40].
The present study has several limitations. First, due to
the cross-sectional study design, our findings could not
prove causal relationships between central fat accumula-
tion and elevated CIMT. Second, the subgroup with
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Third, participants in this study were middle-aged and
elderly Chinese, limiting the generalizability of our find-
ings to other ethnic and age groups.
Conclusion
In conclusion, we have demonstrated that WHtR and
VFA were associated with CIMT, an early marker of ath-
erosclerosis, independent of BMI and other cardiometa-
bolic risk factors. Given the relatively high cost and
complexness of VFA measurement, WHtR could be a
more convenient and appropriate measure of abdominal
obesity in clinical practice.
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HbA1c: Hemoglobin A1c; HOMA-IR: Homeostasis model assessment of
insulin resistance; SD: Standard deviation; OR: Odds ratio; CI: Confidence
interval; SBP: Systolic BP; DBP: Diastolic BP; VAT: Visceral adipose tissue.
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